Alina Mihai

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 536 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 303 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer

Philip Sutera, D.A. Clump, Ronny Kalash et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 83 citations

Medicine, Oncology, Radiation Oncology +12

Acute Toxicity in High-Risk Prostate Cancer Patients Treated With Androgen Suppression and Hypofractionated Intensity-Modulated Radiotherapy

Nadeem Pervez, Cormac Small, M. Mackenzie et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 59 citations

Medicine, Oncology, Urology +17

Inverse vs. forward breast IMRT planning

Alina Mihai, Eileen Rakovitch, Katharina E. Sixel et al. · Medical dosimetry · 2005 · 51 citations

Medicine, Radiation Oncology, Surgery +11